Impact of COVID-19 on cardiovascular testing in the United States versus the rest of the world

Objectives: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-US institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic. Background: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality. Methods: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States. Results: Reductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p < 0.001). Significantly more U.S. facilities reported increased use of telehealth and patient screening measures than non-U.S. facilities, such as temperature checks, symptom screenings, and COVID-19 testing. Reductions in volumes of procedures differed between U.S. regions, with larger declines observed in the Northeast (76%) and Midwest (74%) than in the South (62%) and West (44%). Prevalence of COVID-19, staff redeployments, outpatient centers, and urban centers were associated with greater reductions in volume in U.S. facilities in a multivariable analysis. Conclusions: We observed marked reductions in U.S. cardiovascular testing in the early phase of the pandemic and significant variability between U.S. regions. The association between reductions of volumes and COVID-19 prevalence in the United States highlighted the need for proactive efforts to maintain access to cardiovascular testing in areas most affected by outbreaks of COVID-19 infection

A Search for sleptons and gauginos in Z0 decays

Using a data sample corresponding to 10 000 hadronic Z0 decays, we have searched for the production of sleptons and gauginos in the two-prong decays of Z0. No candidate remains after straightforward selections. For neutralinos, we use selection methods developed in our previous search for neutral Higgs particles. The negative results are translated into improved mass limits and parameter constraints on the minimal supersymmetric extension of the standard model

Charged particle multiplicity distributions in Z0 hadronic decays

This paper presents an analysis of the multiplicity distributions of charged particles produced in Z0 hadronic decays in the DELPHI detector. It is based on a sample of 25364 events. The average multiplicity is &amp;lt;nch&amp;gt;=20.71±0.04(stat)±0.77(syst) and the dispersion D=6.28±0.03(stat)±0.43(syst). The data are compared with the results at lower energies and with the predictions of phenomenological models. The Lund parton shower model describes the data reasonably well. The multiplicity distributions show approximate KNO-scaling. They also show positive forward-backward correlations that are strongest in the central region of rapidity and for particles of opposite charge. © 1991 Springer-Verlag

Search for scalar quarks in Z0 decays

A search has been made for pairs of scalar quarks (squarks) produced in e+e- annihilations at LEP (√s≃MZ0), and decaying into a standard quark and a neutral, non-interacting, stable, massive particle (the lightest supersymmetric particle, LSP). The search has been conducted for differences in the mass of the squark and LSP of 2 GeV/c2 and above. Up squarks with masses below 42 GeV/c2 and down squarks below 43 GeV/c2 were excluded. Six squark flavours degenerate in mass were excluded below 45 GeV/c2.0SCOPUS: ar.jinfo:eu-repo/semantics/publishe